Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[ECG changes after paroxetine. 3 case reports]

A Erfurth1, M Loew, P Dobmeier

  • 1Psychiatrische Klinik der Universität, München.

Der Nervenarzt
|August 26, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mid-term results of anatomical total shoulder arthroplasty for primary osteoarthritis using a short-stemmed cementless humeral component.

The bone & joint journal·2018
Same author

[Results from the German shoulder- and elbow arthroplasty register (SEPR) : Anatomic or reverse shoulder arthroplasty in B2-glenoids?]

Der Orthopade·2017
Same author

The medium- and long-term outcome of total shoulder arthroplasty for primary glenohumeral osteoarthritis in middle-aged patients.

The bone & joint journal·2017
Same author

The connection of temperament with ADHD occurrence and persistence into adulthood - An investigation in 18 year old males.

Journal of affective disorders·2016
Same author

The brief TEMPS-M temperament questionnaire: A psychometric evaluation in an Austrian sample.

Journal of affective disorders·2015
Same author

Lesch typology and temperament in opioid dependence: a cross-sectional study.

Journal of affective disorders·2014
Same journal

[Psychotropic drug research in Germany: challenges of early benefit assessment and precision psychiatry].

Der Nervenarzt·2026
Same journal

[When brain abscesses run in the family…].

Der Nervenarzt·2026
Same journal

[Digital health applications and adherence in depression: a qualitative study from the perspective of healthcare providers].

Der Nervenarzt·2026
Same journal

Der Nervenarzt·2026
Same journal

[Rare genetic diseases with frequent mental symptoms].

Der Nervenarzt·2026
Same journal

Der Nervenarzt·2026
See all related articles

Selective serotonin reuptake inhibitors (SSRIs) generally have fewer cardiac risks than tricyclic antidepressants. However, this study details three cases where paroxetine, an SSRI, caused significant electrocardiogram (ECG) changes in high-risk patients.

Area of Science:

  • Cardiology
  • Pharmacology
  • Clinical Medicine

Background:

  • Selective serotonin reuptuptake inhibitors (SSRIs) are widely prescribed antidepressants.
  • SSRIs are generally considered to have a favorable cardiac safety profile compared to older antidepressants like tricyclic antidepressants (TCAs).
  • Cardiac side effects of SSRIs are rare, but vigilance is necessary in specific patient populations.

Observation:

  • Three high-risk patients were treated with paroxetine, a commonly used SSRI.
  • Clinical observation revealed significant electrocardiogram (ECG) abnormalities in these patients.
  • The observed cardiac events included prolonged QTc interval and severe bradycardia.

Findings:

  • Paroxetine administration was associated with clinically relevant ECG changes in two cases, specifically an increase in QTc time.

Related Experiment Videos

  • Severe bradycardia was observed in two of the three reported cases.
  • These findings suggest a potential for paroxetine to induce cardiac adverse events in susceptible individuals.
  • Implications:

    • The study highlights the importance of cardiac monitoring in high-risk patients receiving SSRIs, even those with a generally good safety profile.
    • Clinicians should be aware of the potential for paroxetine to cause QT prolongation and bradycardia.
    • Further research may be warranted to identify specific risk factors and mechanisms underlying SSRI-induced cardiotoxicity.